YolTech Therapeutics, a clinical-stage biotechnology company developing next-generation in vivo gene editing therapies, today announced that the U.S. Food and Drug Administration (FDA) has cleared the ...

A major breakthrough in cancer research has shown that using CRISPR gene editing technology to turn off a specific gene can help fight chemotherapy resistance in lung cancer. This discovery could open ...

How Cell And Gene Therapy Could Redefine Chronic Disease Treatment. Five companies are racing to bring CRISPR-based and ...

The gene editing tool known as CRISPR-Cas9 is changing what's possible for treating a wide range of diseases caused by ...

In a major step forward for cancer care, researchers at ChristianaCare's Gene Editing Institute have shown that disabling the ...

A new study shows that neurons repair CRISPR-Cas9 cuts in unique, highly predictable ways, unlike dividing cells. Researchers ...

The Epidermolysis Bullosa (EB) market is evolving dynamically due to increased disease awareness and advances in genetic research. EB is a genetic disorder that causes skin fragility and severe ...

This study provides valuable data on the role of Hsd17b7, a gene involved in cholesterol biosynthesis, as a potential regulator of mechanosensory hair cell function. The authors used both zebrafish ...

The frozen remains of a juvenile woolly mammoth named Yuka preserved details about the animal’s last moments alive ...

A leading scientist from San Francisco-based biotech firm Mammoth Biosciences told the Dubai Future Forum today that the ...

"Many challenges we face today are reminders of how painful and frightening it can be to confront an issue in which values ...